Table 3.
Changes in ALT, AST, Alb, and TBiL in both groups before and after treatment.
NAs group | NAs + FZHY group | |||||||
---|---|---|---|---|---|---|---|---|
n | Pre | Post | Post-Pre | n | Pre | Post | Post-Pre | |
ALT (IU/L) | 50 | 54.04 ± 24.73 | 39.40 ± 19.02▲ | −11.14 ± 25.72 | 50 | 49.30 ± 25.29 | 28.50 ± 9.90∗△ | −21.89 ± 25.38 |
AST (IU/L) | 50 | 59.79 ± 24.56 | 41.04 ± 29.93▲ | −15.05 ± 36.42 | 50 | 53.77 ± 24.52 | 29.71 ± 13.60∗∗△ | −23.55 ± 23.10 |
Alb (g/L) | 50 | 35.38 ± 7.82 | 36.94 ± 8.09 | 2.92 ± 16.76 | 50 | 36.06 ± 7.96 | 35.91 ± 9.04 | −1.66 ± 15.76 |
TBiL (mmol/L) | 50 | 25.03 ± 12.85 | 26.20 ± 16.12 | 2.64 ± 16.18 | 50 | 25.97 ± 12.39 | 26.03 ± 14.89 | −2.11 ± 12.83 |
∗ P < 0.05, ▲P < 0.01 versus the Pre of NAs group; ΔP < 0.01versus the Pre of NAs + FZHY group. Alb, serum albumin; TBiL, serum total bilirubin; ALT, serum alanine aminotransferase; AST, serum aspartate aminotransferase.